Duloxetine
Product Images NDC 63629-5174

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 63629-5174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lbl636295174

This appears to be a product label or packaging information for a medication called "Cymbalta 30mg Capsule" manufactured by "Sun Pharma Industries Ltd." The packaging was prepared by an individual named Bryant Ranck under the name "Prepack." The package includes a warning that the medication may cause drowsiness and should be stored at room temperature. The label contains a National Drug Code (NDC) of 6362951741 and an expiration date of MM/YY which is not provided in the text.*

FDA Label Image

Spl Duloxetine Figure1

This chart shows the proportion of patients having a relapse after receiving treatment for a certain period of time. The time from randomization to relapse is measured in days and ranges from 0 to 250. The treatment type is not specified.*

FDA Label Image

Spl Duloxetine Figure10

This text appears to be a graph showing the percentage improvement in pain from baseline for two different treatments. One treatment is labeled as "Placebo" and the other is "Duloxetine 60 mg/120 mg once daily". The x-axis shows different time intervals (0, 10, 20, 23, 40, 50, 260, 70, 80, and 200) and the y-axis shows the percentage improvement in pain from baseline using BOCF (Baseline Observed Carried Forward) analysis.*

FDA Label Image

Spl Duloxetine Figure2

This appears to be a graph depicting the proportion of patients with a relapse in a study comparing a treatment of Placebo vs Dulosetine over a period of time (measured in days) from randomization. The y-axis displays the proportion of patients on a scale of 0 to 8. The x-axis displays a time scale, with intervals marked from 50 to 300.*

FDA Label Image

Spl Duloxetine Figure3

The text is describing a chart that shows the percentage of patients who experienced improvement in pain levels after treatment. The chart also displays the percent improvement in pain from a baseline measurement. Unfortunately, the did not capture a clear image of the chart, so the data may not be very useful.*

FDA Label Image

Spl Duloxetine Figure4

FDA Label Image

Spl Duloxetine Figure5

FDA Label Image

Spl Duloxetine Figure6

FDA Label Image

Spl Duloxetine Figure8

This appears to be a table showing the percentage of patents who experienced improvements in pain from a baseline (measured using the 80CF scale) in relation to a placebo and duloxetine medication taken once daily in doses of 60/120mg. The exact details of the table are not clear, but it seems to be related to medical research or clinical trials.*

FDA Label Image

Spl Duloxetine Figure9

This appears to be a graph showing the "Percent improvement in Pain from Baseline (80CF)" between a Placebo and Duloxetine 60 mg once daily. The x-axis ranges from 210 to 280, and the y-axis ranges from 0 to 100. The graph shows the percentage of patients improved, with Duloxetine outperforming the Placebo.*

FDA Label Image

Spl Duloxetine Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.